Do not take Rizatriptan-CT
- if you are allergic to rizatriptan or any of the other ingredients of this medicine (listed in section 6).
- you have moderately severe or severe high blood pressure, or mild high blood pressure that is not controlled by medication
- you have or have ever had heart problems including heart attack or pain on the chest (angina) or you have experienced heart disease related signs
- you have severe liver or severe kidney problems
- you have had a stroke (cerebrovascular accident CVA) or mini stroke (transient ischaemic attack TIA)
- you have blockage problems with your arteries (peripheral vascular disease)
- you are taking monoamine oxidase (MAO) inhibitors such as moclobemide, phenelzine, tranylcypromine, or pargyline (medicines agains depression), or linezolid (an antibiotic), or if it has been less than two weeks since you stopped taking MAO inhibitors
- you are now taking ergotamine-type medicines, such as ergotamine or dihydro-ergotamine to treat your migraine or methysergide to prevent a migraine attack
- you are taking any other medicine in the same class, such as sumatriptan, naratriptan or zolmitriptan to treat your migraine. (See Taking with other medicines below)
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Rizatriptan-CT.
Warnings and precautions
Talk to your doctor or pharmacist before you take Rizatriptan-CT. Tell your doctor or pharmacist, if:
- you have any of the following risk factors for heart disease: high blood pressure, diabetes, you smoke or you are using nicotine substitution, your family has a history of heart disease, you are a man over 40 years of age, or you are a postmenopausal woman
- you have kidney or liver problems
- you have a particular problem with the way your heart beats (bundle branch block)
- your headache is associated with dizziness, difficulty in walking, lack of coordination or weakness in the leg and arm
- you use herbal preparation containing St. John's wort
- you have had allergic reaction like swelling of the face, lips, tongue and/or throat which may cause difficulty breathing and/or swallowing (angioedema).
- you are taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram oxalate, and fluoxetine or serotonin norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine, and duloxetine for depression as this combination can cause a severe reaction (see section 4 for possible side effects).
- you have had short lived symptoms including chest or throat pain and tightness.
If you take Rizatriptan-CT too often this may result in you getting a chronic headache. In such cases you should contact your doctor as you may have to stop taking Rizatriptan-CT.
Please tell your doctor or pharmacist about your symptoms. Your doctor will decide if you have migraine. You should take Rizatriptan-CT only for a migraine attack. Rizatriptan-CT should not be used to treat headaches that might be caused by other, more serious conditions.
There have been no full studies to look at how safe and effective Rizatriptan-CT is amongst patients older than 65 years.
Children and adolecents
There is limited experience with the use of Rizatriptan-CT in children and adolecents under 18 years of age, therefore children and adolecents should not be given Rizatriptan-CT.
Other medicines and Rizatriptan-CT
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes herbal medicines and those you normally take for a migraine. This is because Rizatriptan-CT can affect the way some medicines work. Also other medicines can affect Rizatriptan-CT.
Do not take Rizatriptan-CT:
- if you are already taking a 5HT1B/1D agonist (sometimes referred to as ‘triptans’), such as sumatriptan, naratriptan or zolmitriptan.
- if you are taking a monoamine oxidase (MAO) inhibitor such as moclobemide, phenelzine, tranylcypromine, linezolid, or pargyline or if it has been less than two weeks since you stopped taking an MAO inhibitor.
- if you use ergotamine-type medicines such as ergotamine or dihydro-ergotamine to treat your migraine
- if you use methysergide to prevent a migraine attack.
The above listed medicines when taken with Rizatriptan-CT may increase the risk of side effects.
You should wait at least 6 hours after taking Rizatriptan-CT before you take ergotamine-type medicines such as ergotamine or dihydro-ergotamine or methysergide.
You should wait at least 24 hours after taking ergotamine-type medicines before taking Rizatriptan-CT.
Ask your doctor for instructions and the risks about taking Rizatriptan-CT
- if you are taking propranolol (see section 3 How to take Rizatriptan-CT)
- if you are taking SSRIs such as sertraline, escitalopram oxalate, and fluoxetine or SNRIs such as venlafaxine, and duloxetine for depression.
Rizatriptan-CT with food and drink
Rizatriptan-CT can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can still take it if you have eaten.
Pregnancy and breast-feeding
It is not known whether Rizatriptan-CT is harmful to an unborn baby when taken by a pregnant woman.
Talk to your doctor before taking this medicine if you are pregnant, planning to get pregnant or are breastfeeding. Your doctor will decide whether you can take this medicine if you are pregnant. Breast- feeding should be avoided for 24 hours after treatment.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
You may feel sleepy or dizzy while taking Rizatriptan-CT. If this happens, do not drive or use any tools or machines.
Rizatriptan-CT contains aspartame (E951) and lactose
Aspartame (E951), a source of phenylalanine, may be harmful for people with phenylketonuria.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.